top of page

Dr. Fabienne Meier-Abt, MD PhD, studied biochemistry at the University of Cambridge, UK, obtained a Doctor of Medicine at Yale University School of Medicine, USA, a PhD in experimental breast cancer research at the Friedrich Miescher Institute for Biomedical Research, Basel CH, and is board-certified in clinical hematology (FMH Hematology). During a personalized health and related technologies (PHRT) transition postdoctoral fellowship at the ETH Zurich, Fabienne gained expertise in proteomic analyses for rare FACS-isolated hematopoietic cells, which she now applies to malignant B cell clones with a special focus on hairy cell leukemia (HCL). From January 2021 onwards, Fabienne will be working clinically in medical genetics focusing on hemato-oncological genetics whilst continuing her research work with Thorsten Zenz’s laboratory. Her main research interests are the proteogenomic characterization of blood cancers and its integration with functional and clinical data.

bottom of page